Skip to main content
Clinical Trials/PACTR202204644214951
PACTR202204644214951
Other
Phase 4

Comparison of the effect of two different doses of nebulized dexmedetomidine as sedative premedication in pediatrics undergoing cochlear implantation

Rania Magdi Ali0 sites50 target enrollmentMarch 29, 2022

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Rania Magdi Ali
Enrollment
50
Status
Other
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 29, 2022
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Rania Magdi Ali

Eligibility Criteria

Inclusion Criteria

  • Age: from 1 to 8 years old
  • sex: male and females
  • American Society of Anesthesiologist physical status (ASA\-PS) I\-II

Exclusion Criteria

  • Children with suspected difficult airway
  • Children with Body Mass Index (BMI) \> 30
  • Children with mental retardation or neurobehavioral disorders
  • History of allergic reactions to Dexmedetomidine

Outcomes

Primary Outcomes

Not specified

Similar Trials